Alny stock premarket

Mar 19, 2020 · Alnylam Pharmaceuticals (NASDAQ:ALNY) initiated with Buy rating and $200 (93% upside) price target at Berenberg. Dicerna Pharmaceuticals (NASDAQ:DRNA) initiated …

ALNY Stock Price and Chart — NASDAQ:ALNY — TradingView — … TradingView India. View live ALNYLAM PHARMACEUTICALS INC chart to track its stock's price action. Find market predictions, ALNY financials and market news. TradingDay.com - ALNY - Alnylam Pharmaceuticals, Inc ... All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither TradingDay.com nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. NASDAQ:ALNY Alnylam Pharmaceuticals Inc. Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating the expression of specific genes. Request Video of ALNY Already a member? Sign in here.

PreMarket Trading Plan Tues May 2 $ANGI ... - Compound Trading

UBS likes Lilly in premarket analyst action - Alnylam ... Jan 23, 2019 · Alnylam Pharmaceuticals (ALNY) initiated with Neutral rating at UBS. Atara Biotherapeutics (ATRA) initiated with Buy rating and $62 (75% upside) price targ Historical Data for Alnylam Pharmaceuticals Inc. (ALNY) Date: Open: High: Low: Close: Volume: Chg % Chg: Adj. Close: Trade Val # Trades: 03/06/20: 114.14: 115.475: 110.35: 113.39: 613.75k-3.52-3.01%: 113.39: 69.31m: 10,479 Alnylam Pharmaceuticals - ALNY - Stock Price & News | The ...

Alnylam Pharmaceuticals Stock Price Forecast, ALNY stock price prediction. The best long-term & short-term Alnylam Pharmaceuticals share price prognosis for 

Stock Price Forecast. The 21 analysts offering 12-month price forecasts for Alnylam Pharmaceuticals Inc have a median target of 142.00, with a high estimate of  21 Mar 2020 Real-time trade and investing ideas on Alnylam Pharmaceuticals, Inc. ALNY from the largest community of traders and investors. 1 Year % Chg 18.03. Market Cap 12.4B. Shares Outstanding 113.1M. Beta 1.93. Dividend (Yield) -. Div Amount -. Ex Div Date -. Earnings Date 2020-04-29. 18 brokerages have issued twelve-month target prices for Alnylam Pharmaceuticals' shares. Their forecasts range from $75.00 to $200.00. On average, they  Based on 11 analysts offering 12 month price targets for Alnylam Pharma in the last 3 months. The average price target is $139.36 with a high forecast of 

ALNY Alnylam Pharmaceuticals, Inc. — Stock Price and ...

Stock Earnings - TD Ameritrade GAAP vs. Non-GAAP Earnings. TD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts. Alnylam Pharmaceuticals, Inc (ALNY) Stock Analysis Buy and ... the stock is 25.5% away from all-time highs of $153.985: alny is down -0% since the beginning of the year: alny is up 34% over the past 12 months: alny is down -1% over the past 1 month: n/a% of all alny investors are betting against alny: num investors short alny has gone up 6% versus last month TTPH - Tetraphase Pharmaceuticals Inc Stock quote ... Find real-time TTPH - Tetraphase Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. Vir Biotechnology and Alnylam Pharma to collaborate on ...

ALNY VWAP Table Volume-Weighted Average Price (VWAP) is a more comprehensive way to calculate the average price that a stock trades at over a given time frame. In the tables below, you can see minute-by-minute VWAP results for ALNY stock, as well as summarized daily values.

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing RNA interference (RNAi) therapeutics. The company's pipeline of investigational RNAi therapeutics focus on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system/ocular diseases. ALNY Stock Price and Chart — NASDAQ:ALNY — TradingView — … TradingView India. View live ALNYLAM PHARMACEUTICALS INC chart to track its stock's price action. Find market predictions, ALNY financials and market news. TradingDay.com - ALNY - Alnylam Pharmaceuticals, Inc ... All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither TradingDay.com nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. NASDAQ:ALNY Alnylam Pharmaceuticals Inc. Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating the expression of specific genes. Request Video of ALNY Already a member? Sign in here.

16 Mar 2020 (ALNY) stock is trading at $98.62 as of 10:52 AM on Monday, Mar 16, a decline of -$2.95, or -2.9% from the previous closing price of $101.57. The  19 Mar 2020 The 52-week price high and low points are important variables to concentrate on when assessing the current and prospective worth of a stock.